相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Identification of metabolism-related long non-coding RNA (lncRNA) signature predicts prognosis and immune infiltrates in hepatocellular carcinoma
Xiaodong Wang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2022)
A novel lipid metabolism-related lncRNA signature predictive of clinical prognosis in cervical cancer
Yanzhen Lu et al.
FRONTIERS IN GENETICS (2022)
LncRNA regulation: New frontiers in epigenetic solutions to drug chemoresistance
Ying Zhou et al.
BIOCHEMICAL PHARMACOLOGY (2021)
LncRNA ZFAS1: Role in tumorigenesis and other diseases
Soudeh Ghafouri-Fard et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Update on First-Line Combination Treatment Approaches in Metastatic Clear-Cell Renal Cell Carcinoma
Bryce R. Christensen et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2021)
The 2021 Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibitor-based Combination Therapies for Treatment-naive Metastatic Clear-cell Renal Cell Carcinoma Are Standard of Care
Jens Bedke et al.
EUROPEAN UROLOGY (2021)
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma
Kevin Bi et al.
CANCER CELL (2021)
ciRS-7 is a prognostic biomarker and potential gene therapy target for renal cell carcinoma
Weipu Mao et al.
MOLECULAR CANCER (2021)
Current status of antigen-specific T-cell immunotherapy for advanced renal-cell carcinoma
Yuexin Xu et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)
The lncRNA Signatures of Genome Instability to Predict Survival in Patients with Renal Cancer
Liang Huang et al.
JOURNAL OF HEALTHCARE ENGINEERING (2021)
Renal cell carcinoma (RCC): fatter is better? A review on the role of obesity in RCC
Fabio Turco et al.
ENDOCRINE-RELATED CANCER (2021)
Serum and urine analysis with gold nanoparticle-assisted laser desorption/ionization mass spectrometry for renal cell carcinoma metabolic biomarkers discovery
Adrian Arendowski et al.
ADVANCES IN MEDICAL SCIENCES (2021)
The Role of lncRNA in the Development of Tumors, including Breast Cancer
Beata Smolarz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Epigenetic Biomarkers of Renal Cell Carcinoma for Liquid Biopsy Tests
Raimonda Kubiliute et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Immune-related eight-lncRNA signature for improving prognosis prediction of lung adenocarcinoma
Yan Chen et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2021)
LncRNA as a multifunctional regulator in cancer multi-drug resistance
Jiaying He et al.
MOLECULAR BIOLOGY REPORTS (2021)
Noncoding RNA therapeutics - challenges and potential solutions
Melanie Winkle et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response
Yuping Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
LncRNA FENDRR Expression Correlates with Tumor Immunogenicity
Maria Cristina Munteanu et al.
GENES (2021)
Tumor-Experienced Human NK Cells Express High Levels of PD-L1 and Inhibit CD8+ T Cell Proliferation
Jessica M. Sierra et al.
FRONTIERS IN IMMUNOLOGY (2021)
Renal Lipid Metabolism Abnormalities in Obesity and Clear Cell Renal Cell Carcinoma
Ion Alexandru Bobulescu et al.
METABOLITES (2021)
First-line Immunotherapy-based Combinations for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis
Fahad Quhal et al.
EUROPEAN UROLOGY ONCOLOGY (2021)
Quantitative proteomic analysis reveals sophisticated metabolic alteration and identifies FMNL1 as a prognostic marker in clear cell renal cell carcinoma
Gui Mal et al.
JOURNAL OF CANCER (2021)
Long noncoding RNAs in cancer metastasis
S. John Liu et al.
NATURE REVIEWS CANCER (2021)
Ensembl 2020
Andrew D. Yates et al.
NUCLEIC ACIDS RESEARCH (2020)
Integration of Lipidomics and Transcriptomics Reveals Reprogramming of the Lipid Metabolism and Composition in Clear Cell Renal Cell Carcinoma
Giuseppe Lucarelli et al.
METABOLITES (2020)
Glutathione Metabolism in Renal Cell Carcinoma Progression and Implications for Therapies
Yi Xiao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Statistical predictions with glmnet
Solveig Engebretsen et al.
CLINICAL EPIGENETICS (2019)
EPIGENETICS Guardians of the oocyte methylome
Kim Baumann
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Neoadjuvant therapy for localized and locally advanced renal cell carcinoma
Ahmet Bindayi et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2018)
Metabolic reprogramming in clear cell renal cell carcinoma
Hiromi I. Wettersten et al.
NATURE REVIEWS NEPHROLOGY (2017)
Outcomes of unselected patients with metastatic clear-cell renal cell carcinoma treated with first-line pazopanib therapy followed by vascular endothelial growth factor receptor tyrosine kinase inhibitors or mammalian target of rapamycin inhibitors: a single institution experience
Marc R. Matrana et al.
BJU INTERNATIONAL (2016)
Prognostic significance of two lipid metabolism enzymes, HADHA and ACAT2, in clear cell renal cell carcinoma
Zuohui Zhao et al.
TUMOR BIOLOGY (2016)
Evolving Immunotherapy Approaches for Renal Cell Carcinoma
Susanna A. Curtis et al.
CURRENT ONCOLOGY REPORTS (2016)
Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma
T. K. Choueiri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge
Katarzyna Tomczak et al.
Wspolczesna Onkologia-Contemporary Oncology (2015)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)